Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

IDEXX Laboratories is poised for growth in the pet healthcare market. Check out why I see a 50% upside in IDXX stock by FY27.

Shares of IDEXX Laboratories Inc. IDXX slipped 1.71% to $460.56 Thursday, on what proved to be an all-around mixed trading ...

Piper Sandler raised the firm’s price target on Idexx Laboratories (IDXX) to $510 from $435 and keeps a Neutral rating on the shares. The firm ...

Piper Sandler analyst David Westenberg maintained a Hold rating on Idexx Laboratories (IDXX – Research Report) today and set a price target of ...

Shares of leading pet healthcare diagnostics provider Idexx Laboratories (NASDAQ: IDXX) were up by 9% this week as of 4 p.m.

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments.

IDEXX Laboratories exceeded fourth-quarter profit and revenue estimates on sales of its animal testing products and price ...

Anne M. Szostak, a director at IDEXX Laboratories Inc. (NASDAQ:IDXX), recently sold 3,000 shares of the company's common stock. The shares were sold at an average price of $465.945, totaling ...

Spire Wealth Management trimmed its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 86.8% ...

Idexx delivered revenue and EPS growth of 6% and 13% in Q4, but its guidance appears to have caught the market's attention. Looking ahead to 2025, management expects the company to grow sales by 4 ...